SOUTH SAN FRANCISCO, Calif. (AP) _ Lyell Immunopharma Inc. (LYEL) on Friday reported a loss of $48.9 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had a loss of 20 cents.
The biotechnology firm posted revenue of $2.8 million in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL
Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News